Mehak Trehan, Associate Consultant at Fortis Healthcare, shared a post on X:
“As the Myeloma Awareness Week reaches its near end, I don’t want to start with the newest drug.
I want to start with the first clue.
The earliest story was not molecular. It was clinical.
What we now teach as ‘CRAB’ began as bedside observation.”
Other articles about Myeloma on oncodaily.